Product
Intravenous Infusion
5 clinical trials
8 indications
Indication
Cancer PainIndication
Idiopathic Inflammatory MyopathiesIndication
Breakthrough PainIndication
Parkinson's diseaseIndication
DyskinesiaIndication
Drug-inducedIndication
Lumbar SurgeryIndication
Central Retinal Vein OcclusionClinical trial
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement Versus Intravenous PCA for Breakthrough Cancer Pain: A Prospective, Randomized, Open Label, Non Inferiority TrialStatus: Withdrawn, Estimated PCD: 2023-05-31
Clinical trial
Optimizing Treatment on Idiopathic Inflammatory MyopathiesStatus: Recruiting, Estimated PCD: 2024-05-06
Clinical trial
Preventing Levodopa Induced Dyskinesia in Parkinson?s Disease With StatinsStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Prospective Study of Enhanced Recovery After Surgery in Orthopaedic Spine Surgery: Administration of Preoperative Oral Versus Intravenous MedicationsStatus: Active (not recruiting), Estimated PCD: 2024-06-15
Clinical trial
Phase Ib Study on Surgical Stabilizer Assisted Retinal Vein Cannulation (RVC) With tPA Infusion Confirmed by Intraoperative Angio-optical Coherence Tomography (Angio-OCT) for the Treatment of Central Retinal Vein Occlusion (CRVO).Status: Withdrawn, Estimated PCD: 2021-12-10